Genpact insider to sell 10,000 shares on 9/14/26

An insider at Genpact Limited has filed a Rule 144 notice to sell 10,000 common shares, valued at about $367,904.

Rhea-AI Filing Summary

Genpact Limited (G) received a notice that insider Balkrishan Kalra intends to sell 10,000 shares of common stock under Rule 144 through broker Morgan Stanley Smith Barney LLC. The planned sale has an approximate aggregate value of $367,904 and is listed for execution on September 14, 2026 on the NYSE.

Key Figures

Shares to be sold: 10,000 shares Approximate aggregate market value: $367,904 Planned sale date: September 14, 2026 +1 more

4 metrics

Shares to be sold 10,000 shares Common stock covered by the Rule 144 notice

Approximate aggregate market value $367,904 Estimated value of the 10,000 shares to be sold

Planned sale date September 14, 2026 Date listed for the Rule 144 sale on the NYSE

Acquisition date of performance shares January 10, 2025 Date the 10,000 performance shares were acquired from the issuer

Key Terms

Rule 144, performance shares, aggregate market value

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

performance shares financial

"Common | 01/10/2025 | Performance Shares | Issuer"

Performance shares are a type of company stock given to executives or employees that only become theirs if the company meets specific goals, like hitting certain profits or growth targets. They motivate leaders to work toward the company’s success, because their additional shares depend on achieving these results.

aggregate market value financial

"Common | Morgan Stanley Smith Barney LLC ... | 10000 | 367904.00"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for Genpact Limited (G)?

It discloses that insider Balkrishan Kalra intends to sell 10,000 shares of Genpact Limited common stock under Rule 144, with an approximate aggregate value of $367,904, through Morgan Stanley Smith Barney LLC on September 14, 2026.

How many Genpact (G) shares are covered by this Rule 144 notice?

The notice covers 10,000 shares of Genpact Limited common stock to be sold. These shares are listed as performance shares that were acquired from the issuer on January 10, 2025.

What is the approximate value of the Genpact (G) shares to be sold?

The filing lists an approximate aggregate market value of $367,904 for the 10,000 shares of Genpact Limited common stock covered by the planned Rule 144 sale.

Who is the insider planning to sell Genpact (G) shares under Rule 144?

The person for whose account the securities are to be sold is Balkrishan Kalra. The filing indicates this relates to common stock, including performance shares acquired from Genpact Limited.

When were the Genpact (G) shares to be sold acquired?

The 10,000 performance shares of Genpact Limited common stock listed for sale were acquired from the issuer on January 10, 2025, according to the securities-to-be-sold section.

Which broker is handling the planned Genpact (G) share sale?

The Rule 144 filing lists Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, New York, as the broker for the planned sale of 10,000 shares of Genpact Limited common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/14/2026 - 04:23 PM Accepted by SEC EDGAR 09/14/2026 - 04:23 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001768217
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	GENPACT LIMITED
SEC File Number	001-33626
Address of Issuer	Canon's Court 22 Victoria Street Hamilton BERMUDA HM 12
Phone	(441) 298 3300
Name of Person for Whose Account the Securities are To Be Sold	BALKRISHAN KALRA
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	10000	367904.00	168034407	09/14/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/10/2025	Performance Shares	Issuer			10000	01/10/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/14/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Balkrishan Kalra
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)